PTEN and cancer: Beyond TP53 and PTEN, 41% of BRCA1 and BRCA2 germline mutation-associated tumors had a likely pathogenic/pathogenic mutation in a cancer gene (defined as COSMIC cancer gene census gene and/or as reported44) (Fig. 3).